BHBerlian Sarasitha Hariawan

Berlian Sarasitha Hariawan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Berlian Sarasitha Hariawan has a total of 39 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Hydro-ethanolic Extraction Modulates Phytochemicals and Bioactivities of Pogostemon cablin Leaves

    by Oktavina K. Putri, Yuly Kusumawati, Dewi Wulansari, Yulfi Zetra, Berlian S. Hariawan, Aqidatul Izza, Made A.S. Dharmayanti

    Pogostemon cablin (Blanco) Benth. is a medicinal plant notable for its diverse secondary metabolites. However, investigations of its bioactive properties beyond essential oils remain scarce. Solvent polarity, especially ethanol concentration in hydro-ethanolic systems, plays a key role in influencing phytochemical composition and related biological activities. This study evaluated the impact of ethanol concentration on the phytochemical profile and bioactivities of P. cablin leaf extracts obtained using ultrasonic-assisted extraction. Quantitative analysis indicated that the HC2 extract (1:1, v/v ethanol–water) contained the highest Total Phenolic Content (TPC) (243.89 ± 56.61 mg GAE g-1 extract) and Total Flavonoid Content (TFC) (26.16 ± 1.98 mg QE g-1). Antioxidant capacity, assessed using the 1,1-diphenyl-2-picrylhydrazyl (DPPH), ferric reducing antioxidant power (FRAP), and 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) assays, exhibited an increasing trend with higher ethanol proportions. Among the extracts, HC3, prepared at a 3:1 (v/v) ethanol-to-water ratio, demonstrated the most pronounced activity, with a DPPH IC₅₀ of 29.52 ± 0.20 µg mL-1, FRAP value of 608.55 ± 2.41 µg TE g-1, and ABTS value of 88.80 ± 0.49 µg TE g-1. Liquid chromatography–tandem mass spectrometry (LC–MS/MS)-based phytochemical profiling revealed a complex metabolite composition dominated by phospholipids, phenolics, flavonoids, amino acids, and coumarins. The extracts exhibited concentration-dependent antimicrobial activity against Streptococcus mutans, Klebsiella pneumoniae, and Candida albicans, with 50–75% hydroethanolic extracts showing notable inhibition. Overall, ethanol concentration markedly influences phytochemical composition and associated bioactivities, highlighting the importance of optimizing solvent systems.

  • Open Access

    The Effect of Zoledronic Acid Injection on the Effectiveness of Chitosan-Coated Ursolic Acid Niosomes for Treating Liver Damage in NDEA-Induced Mice

    by Andang Miatmoko, Dwi Nur’AIni Hidayati Hidayati, Dinda Chaerani, Berlian Sarasitha Hariawan, Devy Maulidya Cahyani, Liew Kai Bin, Esti Hendradi, Retno Sari

    Background: Ursolic Acid (UA) is well known as a BCS class IV terpenoid with anticancer, anti-inflammatory, and antioxidant properties. Niosomes have been reported to improve the bioavailability of poorly water-soluble drugs, and chitosan coating may further increase the bioavailability and liver accumulation. However, macrophage-mediated nanoparticle uptake may affect it. This study aimed to determine the effect of macrophage depletion on the therapeutic and preventive efficacy of chitosan-coated Nio-UA against the hepatotoxic effects of N-nitrosodiethylamine (NDEA) in mice. Methods: Nio-UA was prepared by thin-layer hydration and coated with chitosan via vortexing. In the curative therapy model, mice received NDEA (25 mg/kgBW, intraperitoneally) weekly for 6 weeks, followed by Nio-UA (11 mg/kgBW, orally) every 2 days for 8 doses. In the preventive model, mice were given Nio-UA at the same dose 7 and 3 days before NDEA induction, then weekly with NDEA for 4 weeks. Macrophage depletion was induced with zoledronic acid (ZOL) at a dose of 40 μg/mouse intravenously for 3 days. Results: Chitosan coating increased the niosomal particle size and polydispersity index (PDI) while modifying the ζ-potential. In vivo bilirubin levels differed significantly between the healthy and negative control groups, whereas albumin levels showed no significant difference. ZOL treatment did not significantly alter bilirubin or albumin levels compared to non-ZOL groups in either model. Discussions: The UA niosomes therapy did not significantly improve serum albumin or total bilirubin levels after ZOL injection, suggesting that the ZOL dose injection may have not substantially affect niosome uptake. The effectiveness of macrophage depletion needs further validation. ZOL injection slightly reduced bilirubin levels in the preventive therapy model, may indicate partial depletion of hepatic macrophages and decreased hepatic clearance of Nio-UA and Nio-UA-Cs. These preliminary findings provide a basis for further investigation whether ZOL injection can increase the UA's therapeutic effectiveness. Conclusions: In this exploratory study, ZOL injection did not markedly improve the therapeutic effectiveness of chitosan-coated Nio-UA in preventing or treating the hepatotoxic effects of N-nitrosodiethylamine (NDEA) in mice. Further studies for validating macrophage depletions are required to clariy the mechanism. Keywords: Cancer, Macrophage Depletion, Ursolic Acid, Niosomes, Hepatotoxic Effects, N-nitrosodiethylamine

  • Open Access

    Nanoparticle tools for maximizing oral drug delivery

    by D.M. Cahyani, A.S. Mubarok, B.S. Hariawan, I. Amalina, P. Drake, T. Parumasivam, R.K. Sahu, M.A.S. Rijal, R. Sari, A. Miatmoko

    The biological permeability and water solubility of drugs can pose substantial obstacles to oral drug delivery, the most common mode of drug administration for improving human health. Solubility determines the amount of drug that can be dissolved in solution, whereas permeability is the ability to permeate across biological membranes, determining therapeutic efficacy and safety. Some biological barriers, such as gastrointestinal pH, enzymes, and mucus, may affect the dissolution or absorption of therapeutic drugs. Physical or chemical approaches can be used to modify the water solubility or enhance the permeability. Moreover, nanocarriers, which can increase drug stability through encapsulation, enhance absorption due to their extensive surface area, and facilitate the targeted administration of medications to certain areas, could be useful for drug delivery systems. Nanoparticles can increase drug solubility by particle size reduction, complexation, and drug encapsulation and increase permeation by retention in tumors, opening of tight junctions, membrane fluidization, or intestinal mucoadhesion. Despite the many advantages of nanoparticle drug formulations, they also have several limitations, such as complicated manufacturing processes, nanotoxicity, and stability issues. In this article, we provide a comprehensive description of nanoparticle tools for maximizing oral drug delivery.


  • Open Access

    Nanomaterial application for protein delivery in bone regeneration therapy

    by B.S. Hariawan, A. Miatmoko, Q.K. Anjani, F. Annuryanti, D.B. Kamadjaja, A. Nurkanto, Purwati, D.M. Hariyadi

    Bone fractures must undergo a complex healing process involving intricate cellular and molecular mechanisms. They require a suitable biological environment to restore skeletal stability and resolve inflammation. Scaffolds play a vital role in bone regeneration, thus reducing disease burden. Autologous bone graft represents the gold standard of therapy. However, its application is limited due to various reasons. Nanotechnology, in the form of nanomaterials and nano-drug delivery systems, has been proven to increase the potency of active substances in mimicking extracellular matrix (ECM), thereby providing physical support benefits and enhancing therapeutic effectiveness. Various materials, including protein, metal oxide, hydroxyapatite, and silica are modified with nanoparticle technology for the purposes of tissue regeneration therapy. Moreover, the properties of nanomaterials such as size, seta potential, and surface properties will affect their effectiveness in bone regeneration therapy. This review provides insights that deepen the knowledge of the manufacturing and application of nanomaterials as a therapeutic agent for bone regeneration.


  • Open Access

    Prospective use of amniotic mesenchymal stem cell metabolite products for tissue regeneration

    by Andang Miatmoko, Berlian Sarasitha Hariawan, Devy Maulidya Cahyani, Syarifah Sutra Dewangga, Kevin Ksatria Handoko, Purwati Purwati, Ram Kumar Sahu, Dewi Melani Hariyadi

    Chronic disease can cause tissue and organ damage constituting the largest obstacle to therapy which, in turn, reduces patients’ quality-adjusted life-year. Degenerative diseases such as osteoporosis, Alzheimer’s disease, Parkinson’s disease, and infectious conditions such as hepatitis, cause physical injury to organs. Moreover, damage resulting from chronic conditions such as diabetes can also culminate in the loss of organ function. In these cases, organ transplantation constitutes the therapy of choice, despite the associated problems of immunological rejection, potential disease transmission, and high morbidity rates. Tissue regeneration has the potential to heal or replace tissues and organs damaged by age, disease, or trauma, as well as to treat disabilities. Stem cell use represents an unprecedented strategy for these therapies. However, product availability and mass production remain challenges. A novel therapeutic alternative involving amniotic mesenchymal stem cell metabolite products (AMSC-MP) has been developed using metabolites from stem cells which contain cytokines and growth factors. Its potential role in regenerative therapy has recently been explored, enabling broad pharmacological applications including various gastrointestinal, lung, bladder and renal conditions, as well as the treatment of bone wounds, regeneration and skin aging due to its low immunogenicity and anti-inflammatory effects. The various kinds of growth factors present in AMSC-MP, namely bFGF, VEGF, TGF-β, EGF and KGF, have their respective functions and activities. Each growth factor is formed by different proteins resulting in molecules with various physicochemical properties and levels of stability. This knowledge will assist in the manufacture and application of AMSC-MP as a therapeutic agent.


  • Open Access

    The effect of chitosan addition on cellular uptake and cytotoxicity of ursolic acid niosomes

    by Andang Miatmoko, Berlian S. Hariawan, Devy M. Cahyani, Retno Sari, Aristika Dinaryanti, Eryk Hendrianto

    This study evaluated the cellular uptake and cytotoxicity of low permeable Ursolic acid (UA) on cancer cells using niosomes composed of span 60 and cholesterol. The results showed that the addition of chitosan increased particle sizes and ζ-potentials. The UA niosomes with chitosan layers had higher cytotoxicity in HeLa cells than without chitosan, however, there was no improvement observed for Huh7it cells. Moreover, chitosan layers improved the cellular uptake, which clathrin-mediated endocytosis may determine the cellular transport of UA niosomes. In conclusion, the addition of chitosan improved cellular uptake and cytotoxicity of UA niosomes in the HeLa cells.


  • Open Access

    PEMILIHAN ANALGESIK EKSTERNAL UNTUK MENGATASI NYERI OTOT PADA KULI ANGKUT PUSAT GROSIR SURABAYA

    by Nida Septioning Sukma, Devy Maulidya Cahyani, Yuniar Tri Saskia Revi, Evelyn Clarissa Febiany, Fatihatul Alifiyah, Berlian Sarasitha Hariawan, Iffah Khosyyatillah, Ni’mAtul Khoiriyyah, Savira Putri Ayuningtyas, Firda Rosyidah, et al.

    Di Indonesia rata-rata buruh mengalami nyeri otot dan menggunakan analgesik eksternal untuk menangani nyeri otot. Tujuan dari penelitian ini adalah mengetahui bagaimana penanganan nyeri otot dan apa saja yang memengaruhi pemilihan analgesik eksternal oleh kuli angkut di Pusat Grosir Surabaya (PGS), pengetahuan tentang analgesik eksternal serta peran apoteker dalam pelaksanaan swamedikasi terkait pemilihan analgesik eksternal. Rancangan penelitian yang digunakan adalah cross-sectional. Sampel pada penelitian ini adalah kuli angkut PGS. Data disajikan secara deskriptif dalam bentuk grafik dan tabel berdasarkan jawaban responden pada kuesioner. Total responden berjumlah 100 orang. Mayoritas responden pernah merasakan nyeri di bahu kanan (36) 9,8%. Waktu terjadinya nyeri adalah setelah melakukan aktivitas (84) 82,3% dengan intensitas nyeri sedang (55) 55% dan usaha untuk mengatasi nyeri paling banyak menggunakan obat luar (72) 41,1% jenis obat oles (63) 51,2% dengan efek panas yang diharapkan (80) 74,8%. Alasan dari pemilihan analgesik eksternal adalah khasiat yang ditimbulkan (76) 60,3%. Peran apoteker dalam edukasi analgesik ekstenal masih minim dilihat dari (44) 44% responden memiliki pengetahuan yang kurang mengenai nyeri dan penggunaan analgesik eksternal. Responden banyak memperoleh obat dari toko atau warung (57) 51,8%, apabila nyeri berlanjut kebanyakan responden memilih untuk pergi ke dokter (43) 38,7%.